Billing Beat

New Waived Tests effective 7/1/2014

April 23, 2014

Listed below are the latest tests approved by the FDA as waived tests under CLIA. CPT codes for the following new tests must have the modifier QW to be recognized as a waived test.

CPT Code

Effective Date

Description

87880QW

July 29, 2013

Poly stat Strep A Flip Test

G0434QW

August 1, 2013

Alere iScreen DX Multi-Drugs of Abuse Dip Test

G0434QW

September 10, 2013

Alere iScreen DX Single Dip Card {The Alere iScreen DX Single Dip Card may include a maximum of four drugs in any combination of the 13 claimed drugs}

85018QW

December 12, 2013

Alere HemoPoint H2 System

87804QW

December 13, 2013

Sofia Analyzer and Influenza A+B FIA

G0434QW

February 21, 2014

Ultimate Analysis Cup Inc. UA Cups Test Cards

G0434QW

February 21, 2014

Ultimate Analysis Cup Inc. UA Cups

83516QW

February 27, 2014

Rapid Pathogen Screening, Inc. InflammaDry

 

The new CPT code 83516QW has been assigned for the immunoassay test for the visual, qualitative detection of elevated levels of the MMP-9 protein in human tears, from patients suspected of having dry eye performed using the Rapid Pathogen Screening, Inc. InflammaDry.

MACs will not search their files to either retract payment or retroactively pay claims based on the above changes; however, they will adjust claims impacted by these changes if you bring such claims to your MAC’s attention.

Sign up for Billing Beat